Skip to main content
Log in

Further studies to examine the nature of dexfenfluramine-induced suppression of heroin self-administration

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The present series of experiments sought to investigate further the mechanism by which dexfenfluramine, a selective 5-HT releaser/reuptake inhibitor, reduces heroin self-administration by male Wistar rats. In experiment 1, the effect of combined intravenous heroin and intraperitoneal dexfenfluramine injections on operant responding for food was examined. In experiment 2, the maintenance of dexfenfluramine suppression of heroin self-administration following chronic (7 day) treatment was evaluated. Finally, in experiment 3, the ability of various 5-HT antagonists to block the dexfenfluramine suppression was examined. The results from experiment 1 suggest that sensorimotor deficits/malaise potentially associated with heroin/dexfenfluramine combinations are unlikely to account for the reductions in heroin self-administration. Experiment 2 suggested that the suppressant effect of dexfenfluramine on heroin responding may diminish rapidly following chronic treatment. Finally, central 5-HT1 and/or 5-HT2, but not 5-HT3, receptors may underlie the suppressant effects of dexfenfluramine on heroin self-administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Awouters F, Niemegeers CJE, Megens AAHP, Meert TF, Janssen PAJ (1988) Pharmacological profile of ritanserin: a very specific central serotonin S2-antagonist. Drug Dev Res 15:61–73

    Google Scholar 

  • Blundell JE (1984) Serotonin and appetite. Neuropharmacology 23, 1537–1551

    Google Scholar 

  • Boess FG, Martin IL (1994) Molecular biology of 5-HT receptors. Neuropharmacology 33:275–317

    Google Scholar 

  • Canadian Council of Animal Care (1980) Guide to the care and use of experimental animals. Ottawa, p 84

  • Carroll ME, Lac ST, Asencio M, Kragh R (1990) Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 35:237–244

    Google Scholar 

  • Corrigall WA (1992) A rodent model for nicotine self-administration. In: Boulton A, Baker G, Wu P (eds) Neuromethods, vol. 24: animal models of drug addiction. Humana, Clifton, pp 315–344

    Google Scholar 

  • Craig DA, Clarke DE (1990) Pharmacological characterisation of a neuronal receptor for 5-hydroxytryptamine in guinea-pig ileum with properties similar to the 5-hydroxytryptamine4 receptor. J Pharmacol Exp Ther 252:1378–1386

    Google Scholar 

  • Davies AM, Parker LA (1993) Fenfluramine-induced place aversion in a three-choice appuratus. Pharmacol Biochem Behav 44:595–600

    Google Scholar 

  • Dellavadova L, Parenti M, Tirone F, Groppetti A (1982) Interactions between serotonergic and enkephalinergic neurones in rat striatum and hypothalamus. Eur J Pharmacol 85:29–34

    Google Scholar 

  • Fletcher PJ (1995) Effects ofd-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbensd-amphetamine. Psychopharmacology 118:155–163

    Google Scholar 

  • Fletcher PJ, Ming ZH, Higgins GA (1993) Conditioned place preference induced by microinjection of 8-OH-DPAT into the dorsal or median raphe nuclei. Psychopharmacology 113:31–36

    Google Scholar 

  • Fuller RW, Kurz, KD, Mason NR, Cohen ML (1986) Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67. Eur J Pharmacol 125:71–77

    Google Scholar 

  • Fuller RW, Snoddy HD, Robertson DW (1988) Mechanisms of effects ofd-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release. Pharmacol Biochem Behav 30:715–721

    Google Scholar 

  • Gill K, Amit Z (1989) Serotonin uptake blockers and voluntary alcohol consumption. A review of recent studies. In: Galanter M (ed) Recent developments in alcoholism, vol. 7, Plenum, New York, pp 225–248

    Google Scholar 

  • Gotestam KG, Andersson BE (1975) Self-administration of amphetamine analogues in rats. Pharmacol Biochem Behav 3:229–233

    Google Scholar 

  • Higgins GA, Tomkins DM, Fletcher PJ, Sellers EM (1992) Effect of drugs influencing 5-HT function on ethanol drinking and feeding behaviour in rats: studies using a drinkometer system. Neurosci Biobehav Rev 16:535–552

    Google Scholar 

  • Higgins GA, Wang Y, Sellers EM (1993) Preliminary findings with the indirect 5-HT agonist dexfenfluramine on heroin discrimination and self-administration in rats. Pharmacol Biochem Behav 45:963–966

    Google Scholar 

  • Higgins GA, Wang Y, Corrigall WA, Sellers EM (1994) Influence of 5-HT3 receptor antagonists and the indirect 5-HT agonist, dexfenfluramine, on heroin self-administration in rats. Psychopharmacology 114:611–619

    Google Scholar 

  • Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157–204

    Google Scholar 

  • Koob GF, Vaccarino FJ, Amalric M and Bloom FE (1987) Positive reinforcing effects of drugs: search for neural substrates. In: Engel J, Oreland L (eds) Brain reward systems and abuse. Raven Press, New York, pp 35–50

    Google Scholar 

  • Laferrere B, Wurtman RJ (1989) Effect ofd-fenfluramine on serotonin release in brains of anaesthetised rats. Brain Res 504:258–263

    Google Scholar 

  • Leccese AP, Lyness WH (1984) The effects of putative 5-hydroxytryptamine receptor active agents ond-amphetamine self-administration in controls and in rats with 5,7-dihydroxytryptamine median forebrain bundle lesions. Brain Res 303:153–162

    Google Scholar 

  • Loh EA, Roberts DCS (1990) Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology 101:262–266

    Google Scholar 

  • Lyness WH, Friedle NM, Moore KE (1980) Increased self-administration ofd-amphetamine after destruction of 5-hydroxytryptaminergic neurons. Pharmacol Biochem Behav 12:937–941

    Google Scholar 

  • McCann U, Hatzidimitriou G, Ridenour A, Fischer C, Yuan J, Katz J, Ricaurte G (1994) Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated. J Pharmacol Exp Ther 269:792–798

    Google Scholar 

  • McClelland RC, Sarfaty T, Hernandez L, Hoebel BG (1989) The appetite suppressantd-fenfluramine decreases self-stimulation at a feeding site in the lateral hypothalamus. Pharmacol Biochem Behav 32:411–414

    Google Scholar 

  • McGuirk J, Muscat R, Willner P (1992) Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence. Psychopharmacology 106:401–407

    Google Scholar 

  • Majeed NH, Lason W, Przewlocka B, Przewlocki R (1986) Involvement of endogenous opioid peptides in fenfluramine anorexia. Pharmacol Biochem Behav 25:967–972

    Google Scholar 

  • Neill JC, Cooper SJ (1989). Evidence thatd-fenfluramine anorexia is mediated by 5-HT1 receptors. Psychopharmacology 97:213–218

    Google Scholar 

  • Papasava M, Singer G, Papasava C (1986) Food deprivation fails to potentiate intravenous self-administration of fenfluramine in naive rats. Appetite 7:55–61

    Google Scholar 

  • Richardson NR, Roberts DCS (1991) Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. Life Sci 49:833–840

    Google Scholar 

  • Roberts DCS, Bennett SAL (1993) Heroin self-administration in rats under a progressive ratio schedule of reinforcement. Psychopharmacology 111:215–218

    Google Scholar 

  • Rowland NE, Carlton J (1986) Neurobiology of an anorectic drug: fenfluramine. Prog Neurobiol 27:13–62

    Google Scholar 

  • Rowland NE, Morian KR (1992) Effect of dexfenfluramine on alcohol intake in alcohol-preferringP-rats. Alcohol 9:559–561

    Google Scholar 

  • Samanin R, Mennini T, Bendotti C, Barone D, Caccia S, Garattini S (1989) Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity ofd-fenfluramine in the rat. Neuropharmacology 28:465–469

    Google Scholar 

  • Smith FL, Yu DSL, Smith DG, Leccese AP, Lyness WH (1986) Dietary tryptophan supplements attenuate amphetamine self-administration in the rat. Pharmacol Biochem Behav 25:849–855

    Google Scholar 

  • Smith JE, Shultz K, Co C, Goeders NE, Dworkin SI (1987) Effects of 5,7-dihydroxytryptamine lesions of the nucleus accumbens on rat intravenous morphine self-administration. Pharmacol Biochem Behav 26:607–612

    Google Scholar 

  • Tomkins DM, Sellers EM, Fletcher PJ (1994) Median and dorsal raphe injections of the 5-HT1A agonist, 8-OH DPAT, and the GABAA agonist, muscimol, increase voluntary ethanol intake in Wistar rats. Neuropharmacology 33:349–358

    Google Scholar 

  • Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469–492

    Google Scholar 

  • Wogar MA, Bradshaw CM, Szabadi E (1991) Evidence for an involvement of 5-hydroxytryptaminergic neurones in the maintenance of operant behaviour by positive reinforcement. Psychopharmacology 105:119–124

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Y., Joharchi, N., Fletcher, P.J. et al. Further studies to examine the nature of dexfenfluramine-induced suppression of heroin self-administration. Psychopharmacology 120, 134–141 (1995). https://doi.org/10.1007/BF02246185

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02246185

Key words

Navigation